REFERENCES
- Arlien-Søborg, P. (1992). Solvent neurotoxicity. Boca Raton, FL: CRC Press.
- Bale, A. S., Tu, Y., Carpenter-Hyland, E. P., Chandler, L. J., & Woodward, J. J. (2005). Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience, 130, 197–206.
- Balster, R. L. (1991). Drug abuse potential evaluation in animals. British Journal of Addiction, 86, 1549–1558.
- Balster, R. L. (1997). Inhalant abuse, a forgotten problem [Problems of Drug Dependence 1996: Proceedings of the 58th annual scientific meeting]. NIDA Research Monograph Series, 174, 3–8.
- Balster, R. L. (1998). Neural basis of inhalant abuse. Drug and Alcohol Dependence, 51, 207–214.
- Beckstead, M. J., Weiner, J. L., Eger, E. I., 2nd, Gong, D. H., & Mihic, S. J. (2000). Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Molecular Pharmacology, 57, 1199–1205.
- Blokhina, E. A., Dravolina, O. A., Bespalov, A. Y., Balster, R. L., & Zvartau, E. E. (2004). Intravenous self-administration of abused solvents and anesthetics in mice. European Journal of Pharmacology, 485, 211–218.
- Bowen, S. E. (2009). Time-course of the ethanol-like discriminative stimulus effects of abused inhalants in mice. Pharmacology Biochemistry and Behavior, 91, 345–350.
- Bowen, S. E., Batis, J. C., Paez-Martinez, N., & Cruz, S. L. (2006). The last decade on solvent research in animal models of abuse: Mechanistic and behavioral effects. Neurotoxicology and Teratology, 28, 636–647.
- Brouette, T., & Anton, R. (2001). Clinical review of inhalants. The American Journal on Addictions, 10, 79–94.
- Cruz, S.L., & Ambrosio, E. (2009). Experimental models for the study of abused drugs. In L. L. Rocha-Arrieta, & V. Granados-Soto (Eds.), Models of neuropharmacology (pp. 229–240). Trivandrum: Transworld Research Network.
- Cruz, S. L., Balster, R. L., & Woodward, J. J. (2000). Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. British Journal of Pharmacology, 131, 1303–1308.
- Cruz, S. L., & Bowen, S. E. (2008). Inhalant abuse. In M. Méndez Ubach, & R. Mondragón-Ceballos (Eds.), Neural mechanisms of action of drugs of abuse and natural reinforcers (pp. 61–87). Trivandrum: Research Signpost.
- Cruz, S. L., Mirshahi, T., Thomas, B., Balster, R. L., & Woodward, J. J. (1998). Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics, 286, 334–340.
- Cruz, S. L., Orta-Salazar, G., Gauthereau, M. Y., Millan-Perez Peña, L., & Salinas-Stefanón, E. M. (2003). Inhibition of cardiac sodium currents by toluene exposure. British Journal of Pharmacology, 140, 653–660.
- Dinwiddie, S. H. (1994). Abuse of inhalants: A review. Addiction, 89, 925–939.
- Eisenberg, D. P. (2003). Neurotoxicity and mechanisms of toluene abuse. The Einstein Quarterly Journal of Biology and Medicine, 19, 150–159.
- Evans, E. B., & Balster, R. L. (1991). CNS depressant effects of volatile organic solvents. Neuroscience and Biobehavioral Review, 15, 233–241.
- Filley, C. M., Halliday, W., & Kleinschmidt-DeMasters, B. K. (2004). The effects of toluene on the central nervous system. Journal of Neuropathology and Experimental Neurology, 63, 1–12.
- Flanagan, R. J., & Ives, R. J. (1994). Volatile substance abuse. Bulletin on Narcotics, 46, 49–78.
- Freedenthal, S., Vaughn, M. G., Jenson, J. M., & Howard, M. O. (2007). Inhalant use and suicidality among incarcerated youth. Drug and Alcohol Dependence, 90, 81–88.
- Koob, G. F., & Le Moal, M. (2006). Neurobiology of addiction. San Diego, CA: Academic Press.
- Krasowski, M. D. (2000). Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels. Neuropharmacology, 39, 1168–1183.
- Lobo, I. A. (2004). Inhalants. Drugs: The straight facts. New York: Chelsea House.
- Lorenc, J. D. (2003). Inhalant abuse in the pediatric population: A persistent challenge. Current Opinion in Pediatrics, 15, 204–209.
- Lubman, D. I., Hides, L., & Yücel, M. (2006). Inhalant misuse in youth: Time for a coordinated response. The Medical Journal of Australia, 185, 327–330.
- MacIver, M. B. (2009). Abused inhalants enhance GABA-mediated synaptic inhibition. Neuropsychopharmacology, 34, 2296–2304.
- MacLean, S. (2008). Volatile bodies: Stories of corporeal pleasure and damage in marginalised young people's drug use. International Journal of Drug Policy, 19, 375–383.
- Medina-Mora, M. E., & Real, T. (2008). Epidemiology of inhalant use. Current Opinion in Psychiatry, 21, 247–251.
- Ridenour, T. A. (2005). Inhalants: Not to be taken lightly anymore. Current Opinion in Psychiatry, 18, 243–247.
- Ridenour, T. A., Bray, B. C., & Cottler, L. B. (2007). Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults. Drug and Alcohol Dependence, 91, 40–49.
- Riegel, A. C., & French, E. D. (1999). Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride. Pharmacology Biochemistry and Behavior, 62, 399–402.
- Sharp, C. W., Rosenberg, N., & Beauvais, F. (2008). Substance abuse: Inhalant-related disorders. In A. Tasman, J. Kay, J. A. Lieberman, M. B. First, & M. Maj (Eds.), Psychiatry (3rd ed., pp. 1127–1148). New York, NY: John Wiley.
- Shelton, K. L. (2009). Discriminative stimulus effects of inhaled 1,1,1-trichloroethane in mice: Comparison to other hydrocarbon vapors and volatile anesthetics. Psychopharmacology, 203, 431–440.
- Snyder, R. (2002). Benzene and leukemia. Critical Reviews in Toxicology, 32, 155–210.
- Weber, L. W., Boll, M., & Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Critical Reviews in Toxicology, 33, 105–136.
- White, R. F., & Proctor, S. P. (1997). Solvents and neurotoxicity. The Lancet, 349, 1239–1243.
- Williams, J. F., Storck, M.; The Committee on Substance Abuse (Committee on Native American Child Health). (2007). Inhalant abuse. American Academy of Pediatrics, 119, 1009–1017.
- Willner, P. (1995). Animal models of depression: Validity and applications. Advances in Biochemistry and Psychopharmacology, 49, 19–41.
- Wise, R. A., & Gardner, E. L. (2004). Animal models of addiction. In D. S. Charney, & E. J. Nestler (Eds.), Neurobiology of Mental Illness (2nd ed., pp. 683–697). New York: Oxford University Press.
- Wu, L. T., & Howard, M. O. (2007). Psychiatric disorders in inhalant users: Results from the National Epidemiologic Survey on alcohol and related conditions. Drug and Alcohol Dependence, 88, 146–155.